Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Liquidia | 707 | 2023q3 | |||||||||
Madrigal Pharmaceuticals | 3,943 | 2023q1 | |||||||||
Maravai LifeSciences Hold... | 1,978 | 2024q2 | |||||||||
Marker Therapeutics | 332 | 2021 | |||||||||
Masimo | 6,338 | 2023q2 | |||||||||
McKesson | 80,077 | 2025q1 | |||||||||
Medifast | 770 | 2023q3 | |||||||||
MediWound | 90 | 2023q1 | |||||||||
Medpace Holdings | 11,922 | 2023q2 | |||||||||
Medtronic | 105,402 | 2024q2 | |||||||||
Merck | 74,167 | 2021 | |||||||||
Merck & Company | 318,556 | 2023 | |||||||||
Merit Medical Systems | 3,667 | 2023q3 | |||||||||
Mettler-Toledo Internatio... | 22,402 | 2023q3 | |||||||||
Moderna | 29,561 | 2023q3 | |||||||||
ModivCare | 301 | 2022 | |||||||||
Molina Healthcare | 19,320 | 2023q3 | |||||||||
Motus GI Holdings | 9 | 2022q3 | |||||||||
Myriad Genetics | 1,581 | 2024q2 | |||||||||
NanoViricides | 17 | 2022q2 |